NAVIDEA BIOPHARMACEUTICALS, INC. reports

Company location: Dublin, OH
Fiscal year end: 31 December

NAVIDEA BIOPHARMACEUTICALS, INC. has filed 1,465 SEC EDGAR filings since 07 Feb 1995

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 876-900 of 949 matching filings.

Per page

25

Current page

36

SC 13G/A File 005-43603

PLATINUM-MONTAUR LIFE SCIENCES LLC SC 13G/A 12-31-2010

Filing date: 22 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-35076

8-K filing

Filing date: 14 Feb 2011
Reporting date: 14 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

CERTNYS File 001-35076

AUTO-GENERATED PAPER DOCUMENT

Filing date: 08 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-A12B File 001-35076

8-A12B filing

Filing date: 08 Feb 2011
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26520

8-K filing

Filing date: 07 Feb 2011
Reporting date: 07 Feb 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 27 Dec 2010
Reporting date: 20 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26520

8-K filing

Filing date: 27 Dec 2010
Reporting date: 20 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2010
Reporting date: 21 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2010
Reporting date: 21 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2010
Reporting date: 21 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2010
Reporting date: 21 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 22 Dec 2010
Reporting date: 21 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 21 Dec 2010
Reporting date: 20 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Dec 2010
Reporting date: 14 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Dec 2010
Reporting date: 14 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26520

8-K filing

Filing date: 14 Dec 2010
Reporting date: 13 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 10 Dec 2010
Reporting date: 08 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26520

8-K filing

Filing date: 06 Dec 2010
Reporting date: 01 Dec 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 Nov 2010
Reporting date: 17 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 17 Nov 2010
Reporting date: 15 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Nov 2010
Reporting date: 15 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Nov 2010
Reporting date: 15 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Nov 2010
Reporting date: 15 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 16 Nov 2010
Reporting date: 15 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 16 Nov 2010
Reporting date: 15 Nov 2010
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .